GWH experienced a dramatic operational contraction with revenue substantially declining while the company more than doubled its outstanding share count, indicating significant financial distress.
The company appears to be in severe operational difficulty, with revenue falling substantially alongside massive reductions in inventory and receivables that suggest minimal business activity. The doubling of shares outstanding from 12.1M to 27.2M indicates significant equity dilution, likely from emergency fundraising efforts to sustain operations.
GWH's financial position deteriorated markedly, with revenue declining substantially to $1.6M while inventory collapsed by 97.5% to just $140K, suggesting minimal production capacity. Despite these operational challenges, losses improved meaningfully across gross profit, operating income, and cash flow metrics, primarily due to reduced R&D spending and capital expenditures. The company's stockholders equity fell 70% to $8.6M while share count more than doubled, reflecting substantial dilution from what appears to be distressed equity financing.
Inventory drawn down 97.5% — strong sell-through or deliberate destocking; watch for supply constraints.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Revenue declined 74.9% — significant demand weakness or market share loss warrants investigation.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Capex reduced 53.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Current assets declined 39.5% — monitor working capital adequacy and short-term liquidity.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Operating cash flow surged 30.4% — exceptional cash generation, highest quality earnings signal.
R&D spending cut 29.5% — could signal cost discipline or concerning reduction in innovation investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →